RE:RE:RE:RE:RE:if they can close the riplazym partnership H1 Yes, I got fleeced, too, but jumped out before the carnage. But I bought a few rights and grabbed much more at $7-8 to see if Galbraith can do any better as they seem to executing a few things at least. Thomson would have seen enough to go forward or shut it down. They went forward. Moran was a pure science guy and he still deeply believes in 4050. Same with Laurin even without shares. It certainly does make me wonder why no big pharma put a nickel into PLI with those multiple fibrosis results especially in such a tough disease as Alstrom. I understood that Pierre asked over $1B for partnership for 4050 and it was close but too rich for Boehringers blood. Who knows the real story and it doesn't look stellar but Thomson is no fool and probably demanded the cram down to stay alive. No one could say no. Individual investors could have raised quite a bit in a rights offering to go forward but didn't get a chance. At market cap of $200M previously at $2.6B, I think it is a decent high risk / high reward play with CMC consultant on board for 2 years to make sure nothing screws up. How they spent over $500M during past 4 years and didn't do a single placebo test for 4050 is crazy with such excellent results in 5 organs. They have to speed up or they will get nothing back. Quicker they sell Ryplazim, the better - but there is that pediatric voucher, though.
tomperns wrote: Stickbuphoon, you are one of the most respected posters here for years. I used to be a shareholder and got fleeced like most here. How is it that you still have hope here? Didn't you ever wonder why no big pharma put in a cent here considering poutine shack Laurin claimed he had the cure for fibrosis? I'm not talking about slowing down fibrosis; he claimed 4050 REVERSED fibrosis. Bottom line is Laurin was no better than a used car salesman who duped TV and now everyone believes that everything will change?